DataMeds AI's Corexa Health enters agreement for commercial supply of six FDA-recommended peptides

DataMeds AI's pharmacy unit Corexa Health entered an agreement to commercially supply bulk drug substances and active pharmaceutical ingredients for six FDA-recommended peptides — BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax — and intends to begin dispensing compounded prescriptions in November 2026.

Detected & updated continuously · Source: Nebula